The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Borrower

T••••••••• I••

Healthcare & Pharmaceuticalsgroup grade Aoff every schedule since Sep 30, 2023sponsor unattributed
See every lender's markFind rescue capital
More
Special situations PE firms

Nothing material in the last 200 days. Last change: 30 Sep 2023, $17.5M principal held by 1 lender; matures Apr 2027.

Principal held
at least $17.5M
sum of BDC pieces, a lower bound
Fair value
$12.3M
100c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
Apr 1, 2027
no dated debt inside 24 months
On the tape since
Sep 30, 2023
latest Sep 30, 2023
Events
2
dated, non-routine
Lender marks
each lender's own fair value over cost at Sep 30, 2023, folded to one row per lender
LenderExposureCurrent markQoQ change
M••••• F•••••••• I••••••••• C•••$17.5M100¢new this quarter
Every BDC piece · 1 position across 1 lenderlargest principal first, with instrument and rate
BDCInstrumentPrincipalFair valueRate
M••••• F•••••••• I••••••••• C•••term loan first lien
F•••• L••• S•••••• D••• S•••+586, 1.00% F•••• M••••••• D••• 04/01/27
$17.5M$12.3M
100c
S+586 bp
Capital structure as the BDCs see it
latest quarter end Sep 30, 2023
FacilityHeldOn costPricingMaturityBDCs
first lien term loan first lien
exited Sep 30, 2023
at least $17.5M100cS+586 bpApr 1, 20271
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Sep 30, 20231$17.5M$12.3M100c0
What changed
Every change including routine ones
Identity
Group key
TISSUETECHTISSUETECHderivedthe codename stem after legal suffixes and deal words
Spellings
1 across 1 BDCderived
Industry
Healthcare & Pharmaceuticalsreportedas one filer wrote it